BRIEF published on 05/23/2025 at 07:57, 1 year 5 months ago AB Science renforce sa trésorerie avec une augmentation de capital Euronext Paris Financement Augmentation De Capital Investisseurs AB Science
BRIEF published on 05/23/2025 at 07:57, 1 year 5 months ago AB Science strengthens its cash flow with a capital increase Euronext Paris Investors Funding Capital Increase AB Science
PRESS RELEASE published on 05/23/2025 at 07:52, 1 year 5 months ago AB Science : AB Science a réalisé avec succès une augmentation de capital de 1,8 million d’euros renforçant sa trésorerie et couvrant ses besoins de financement. Découvrez les détails dans ce communiqué de presse Augmentation De Capital Trésorerie AB Science Masitinib AB8939
PRESS RELEASE published on 05/23/2025 at 07:52, 1 year 5 months ago AB Science announces the settlement delivery of its latest capital increase for €1.8 million AB Science settles €1.8 million capital increase to strengthen cash position and cover financing needs; focuses on innovative drug development for various diseases Healthcare Industry Financial News Capital Increase Drug Development AB Science
BRIEF published on 05/20/2025 at 07:54, 1 year 5 months ago AB Science Completes EUR 1.8 Million Private Placement Private Placement Euronext Paris Share Warrants AB Science AB8939 Development
BRIEF published on 05/20/2025 at 07:54, 1 year 5 months ago AB Science finalise un placement privé de 1,8 million d'euros Euronext Paris Placement Privé Bons De Souscription D'actions AB Science Développement AB8939
PRESS RELEASE published on 05/20/2025 at 07:49, 1 year 5 months ago AB Science announces the successful completion of a EUR 1.8 million private placement AB Science successfully completes EUR 1.8 million private placement for clinical development. New shares issued with warrants attached for financing ongoing activities Private Placement Capital Increase Clinical Development Share Issuance AB Science
PRESS RELEASE published on 05/20/2025 at 07:49, 1 year 5 months ago AB Science annonce le succès d'un placement privé de 1,8 millions d'euros AB Science annonce le succès d’un placement privé d’environ 1,8 million d’euros pour financer le développement clinique du programme AB8939 Financement Placement Privé Développement Clinique AB Science AB8939
BRIEF published on 05/19/2025 at 07:56, 1 year 5 months ago AB Science obtient un brevet en Chine pour le masitinib contre la COVID-19 COVID-19 Antiviral AB Science Masitinib Brevet Chinois
BRIEF published on 05/19/2025 at 07:56, 1 year 5 months ago AB Science obtains a patent in China for masitinib against COVID-19 COVID-19 Antiviral AB Science Masitinib Chinese Patent
Published on 11/04/2026 at 00:05, 8 hours 52 minutes ago Scoping Study Begins for High-Grade Underground Mine Feed
Published on 11/04/2026 at 00:00, 8 hours 57 minutes ago RE Royalties Launches $5 Million Series 5 Green Bond Offering and Provides Strategic Growth Update
Published on 11/03/2026 at 23:30, 9 hours 27 minutes ago AT&T and Amdocs Expand Collaboration, Bringing Together Amdocs aOS and AT&T's AI-Enabled Framework to Simplify Operations and Improve Customer Experiences
Published on 11/03/2026 at 23:30, 9 hours 27 minutes ago GGL Resources Corp. Issues Post-Consolidation Shares to Strategic Metals Ltd.
Published on 11/04/2026 at 08:37, 20 minutes ago Blue Elephant Energy takes over substation from Bayernwerk Netz – State Secretary Tobias Gotthardt visits the Schafhöfen solar park
Published on 11/04/2026 at 08:05, 52 minutes ago Corero Network Security Accelerates International Growth with Strategic Investment in Regional Leadership and Partnerships
Published on 11/04/2026 at 08:05, 52 minutes ago KFC Brings the Doom: New Marvel-Inspired Menu Lands Ahead of Marvel Studios' "Avengers: Doomsday"
Published on 11/04/2026 at 08:00, 57 minutes ago Key data for the 18th capital increase of the Akara Swiss Diversity Property Fund PK (Akara Fund)
Published on 11/04/2026 at 08:00, 57 minutes ago Données de base pour la 18ème augmentation de capital de l’Akara Swiss Diversity Property Fund PK (fonds Akara)
Published on 11/03/2026 at 18:39, 14 hours 18 minutes ago NRJ Group - Information relative aux droits de vote au 31.10.2026 (French & English)
Published on 11/03/2026 at 18:00, 14 hours 57 minutes ago Outstanding Shares and Voting Rights Monthly Statement - 31 October 2026
Published on 11/03/2026 at 18:00, 14 hours 57 minutes ago Publication mensuelle du nombre d’actions composant le capital et du nombre total de droits de vote - 31 octobre 2026
Published on 11/03/2026 at 17:45, 15 hours 12 minutes ago Declaration of voting rights at the end of October 2026
Published on 11/03/2026 at 17:45, 15 hours 12 minutes ago Déclaration des droits de vote à fin octobre 2026
